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Abstract
Pesticides, weed control chemicals, and polycyclic aromatic hydrocarbons (PAHs) are cytotoxic,
carcinogenic, and toxic chemicals of concern. The toxic effects and health related issues of PAHs
in humans necessitate the urgent need to investigate the binding mechanism of PAHs with
biological specimen for biomedical diagnosis. This study investigated the binding of three PAHs
(anthracene, pyrene, and naphthalene) with human serum albumin (HSA) and bovine serum
albumin (BSA), proteins responsible for the delivery of drug molecules and other important
metabolites to various targets. Specifically, the influence of the temperature, PAH type, and PAH
concentrations on HSA/BSA emission property was investigated. The binding constant (K) and
stoichiometry of PAH-HSA/BSA complexes were also determined from the emission data using a
modified Stern-Volmer equation. The thermodynamic properties (Gibbs free energy (∆G),
enthalpy (∆H), and entropy (∆S)) of PAH-BSA/HSA complexation were also determined from
emission data using Van’t Hoff equation.

The emission spectra, the calculated K and

thermodynamic parameters of PAH-HSA/BSA complexation were found to be PAH and
temperature dependent. The large values of the calculated binding constant and ΔG indicated high
affinity and strong bindings of PAH with HSA/BSA. The influence of PAHs on triple negative
breast cancer (TNBC) cells viability was further investigated. The result of cytotoxicity suggested
that the viability of TNBC cells is PAH and concentration dependent.
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1 CHAPTER 1
Introduction
Many infer the root behind many illnesses are family history and/or genetics oriented. While
it is indeed important to take the family history aspect into consideration, it is justifiably important
to consider diet and environmental exposure. There are environmental and food scientists who
research and take into account the exposure of toxic compounds through air and food and drink
consumption. Many questions in the biomedical community are being researched for answers.
Understanding the interaction of polycyclic aromatic hydrocarbons (PAHs) with human serum
albumin (HSA) and bovine serum albumin (BSA) along with its cytotoxic effects on triple negative
breast cancer (TNBC) cells was the primary focus of this thesis. It is evident that PAHs are found
pervasively in the environment. Preventing human exposure to compounds of this sort is nearly
impossible because of its ubiquities in nature. These hydrocarbons in particular are evident to
have interaction with human specimen as it will be seen throughout this thesis.
1.1 Research Objectives
While it is impossible to eliminate human exposure, this research was conducted in hopes
of investigating interactions of the PAHs with humans on a molecular level. Not only for purposes
of this thesis is this research relevant, but the understanding of the cytotoxic chemicals of interest
is imperative because it enables scientists to understand the interactions of the PAHs with the
human and the animal specimen. The objectives of the study are:
1.1.1. To investigate the influences of PAHs on the binding and emission spectra of
human and bovine serum albumin. The emission spectra of serum albumin will allow accurate
determination of how the PAHs are interacting with the serum proteins. This involves determining
the binding constant and stoichiometry of PAH-serum albumin complexes.
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1.1.2. To examine the thermodynamic properties of PAH-BSA/HSA complexes. The
calculated thermodynamic variables will aid in showing the feasibility of the reactions.
Thermodynamic variables to be calculated are enthalpy (∆H), entropy (∆S), and Gibbs free energy
(∆G). This objective will also show if the effects of these properties are analyte and temperature
dependent.
1.1.3. To investigate the effect of PAHs on cell-viability and on TNBC cells. This
objective will provide the interdisciplinary focus by understanding the biological effects on the
cellular level. This objective was investigated in collaboration with Dr. Checo J. Rorie Assistant
Professor in the Biology Department at North Carolina Agricultural and Technical State University
(NCAT).
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CHAPTER 2
Literature Review
2.1 Polycyclic Aromatic Hydrocarbons
Polycyclic aromatic hydrocarbons (PAHs or polyaromatic hydrocarbons) are known to be
very ubiquitous in nature. These persistent organic compounds (POCs) in their purest form can be
anywhere from colorless to a white or pale yellow-green color 1, 2. These preponderant constituents
of air are formed vastly by the incomplete combustion of products (i.e. garbage, oil, coal, gas and
vegetation) 3. They are known to exist in more than 100 different combinations. Because of their
potential cytotoxic, mutagenic and genotoxic effects to the human population they are of
increasing interest in the biomedical community

1-13

. These hydrocarbons have the feasibility of

staying in the environment for long periods of time because of their inability to burn easy

2,9

.

Although PAHs exist in the environment as a whole, their concentrations vary significantly
throughout. There are substantiated differences in the concentrations of PAHs in rural areas versus
that of urban areas 10. This is due to more anthropogenic emissions of PAHs in the urban areas. It
was suggested that the influence of vehicle and domestic emissions had major influences on the
elevated PAH emissions in urban areas 1-8, 10.
Polyaromatic hyrdrocarbons are often described as simple or complex carbon and
hydrogen containing compounds containing at least 2 or 3 fused benzene rings (other rings that
are not 6-membered may be fused to the benzene rings as well) 1-2, 4-7, 8-15. There still remains some
controversy whether to count naphthalene as a PAH because in actuality it is a bicyclic compound
(see Figure 2.2.1). However, naphthalene exhibits many of the same characteristics as all other
PAHs. Polycyclic aromatic hydrocarbons are distributed throughout the atmosphere dependent
upon location. These compounds of interest possess very distinct ultraviolet (UV) absorbance
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spectra. The spectra is dependent upon each aromatic ring and its location to the rings it may be
fused with. As a result, no single PAH having the same spectra 8. As it will be shown in the results
section, most PAH are also fluorescent as well, emitting distinct wavelengths of light upon
excitement. They are known to have low solubility in water (especially those with three or more
fused rings) along with a low vapor pressure 3. As a result, at ambient temperature most PAHs are
present in the air 2-3. The PAHs with a higher molecular weight are mostly present in the gas phase.
On the contrary, PAHs with a lower molecular weight are found adsorbed on particles dispensed
in the air 3. Thus, resulting in these compounds being one of the first to be identified as a potential
carcinogen 3. It was suggested that there is increased suspicion that increase in molecular weight
increases the carcinogenicity while decreasing the adverse effects of exposure within 24 hours
(better known as acute toxicity) 3. These lipophilic hydrocarbons and derivatives are formed
through the incomplete combustion of organic material. Some of this combustion is what some
may classify as naturally occurring or natural combustion such as volcanic eruptions and forest
fire. However, most of this emission is caused by humans; from vehicular emissions to industrial
emissions 3. Because of the exposure being able to be carcinogenic, many countries have put nonmandatory limits on anthropogenic emissions. PAHs can be synthesized through a host of
mechanistic approaches. Many scientists have geared their research toward unraveling how these
PAHs are found through nature. Polyaromatic hydrocarbons are the most stable form of
hydrocarbons. They usually appear as complex mixtures rather than single compounds 3. Because
PAHs do not burn very easily (extreme temperatures are need to cause decomposition) they can
remain in the environment for long periods of time 2.
Most PAHs are used to conduct research, however, some are still used to make dyes,
plastic, pesticides, and even some are used in synthesizing some medications

2-3, 6, 7

. Whilst it is
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known that many of these compounds in the human body can have adverse effects, it is also
imperative to understand the human body is variant in response. One of the most common ways
these contaminants are presented to the body is through the inhalation of contaminated air 2, 7, 9-10.
If a family lives near a hazardous waste site, they are easily exposed to these PAHs by the air they
breathe. Because of their high volatility it makes it easier for the PAHs to convert into the vapor
phase thus causing them to be one of the constituents in the air. Also, if a family has an open wood
fireplace in their home, they could be exposed to these hazardous compounds. Another method of
contact is through eating and drinking food and water that are contaminated with the PAHs. A lot
of times when grilling food with coal, the meats are then exposed to these PAHs formed and those
partaking in eating the grilled food are exposed to them. This could explain the reasoning for it
being strongly advised to limit the intake of grilled food and to avoid charring food. They can also
enter the body through skin contact with contaminated products (heavy oil, coal tar, etc.) 1-16. Once
PAHs enter the body they are readily stored in fats and tissues. The primary target organs for these
compounds include the liver and kidneys. It is known that the body rids (~90%) most of the PAH
contamination in a matter of days 2.
There is no clinical or scientific proof that PAHs are the primary cause of cancer or other
health defects in humans. However, a number of selected PAHs have caused tumors in laboratory
animals that were exposed to them in high concentrations. Mice were exposed to PAHs through
their food and by skin contact 2. As a result of the exposure, these laboratory animals developed
stomach, skin and lung cancers. The affects PAHs will have on human health depends mainly on
the length of time exposed, the amount of PAH exposure and the toxicity with regards to the types
of exposure 3. However, some non-cancer health effects of long term PAH exposure may include
cataracts, kidney damage, liver damage and jaundice. The ability of most PAH mixtures to cause
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or lead to human cancer has been thought of since the late 1700s. This was discovered when Sir
Percival Pott was able to successfully demonstrate the correlation between exposure of chimney
soot and the incident of scrotum cancer 13.
Polyaromatic hydrocarbons are mostly formed during the incomplete combustion and
pyrolysis (followed by pyrosynthesis) of fossil fuels or wood, and from the release of petroleum
products (such as oil spills). They are also found in coal combustion which is the key primary
fossil fuel that is responsible for about 27% of the world’s energy consumption

1,4,6,7,8,10

. It is

responsible for about 70% of energy consumption in China (about 45% greater than the world
average). Whilst being a global provider of energy, coal combustion, gasification, carbonization
and liquefication are all major sources of the formation of PAHs. In the conversion process, coal
pyrolysis and pyrosynthesis are important factors in the formation of the PAHs 3. Pyrolysis shall
be defined as the thermochemical decomposition of organic material at elevated temperatures. At
a specific temperature, a larger organic compound is in its molecular vibrational state. Textbook
knowledge suggests that the frequency at which a molecule vibrates is directly proportional to the
amount of heat (energy) applied 3. Therefore, at very high temperatures, the molecule will have
elevated vibrations. At this point in time, the molecules are stretched and begin breaking down
into smaller molecules.
After pyrolysis of the bigger molecules takes place pyrosynthesis, the thermochemical
synthesis (fusion) of free radicals (as a result of pyrolysis) to form more complex compounds
(PAHs), takes place. Pyrolysis is subsequently followed by pyrosynthesis. Thus yielding some of
the most dangerous PAHs known to date. Figure 2.1 below gives a general schematic of pyrolysis
followed by pyrosynthesis thus resulting in the formation of the PAHs. It was noted the following
in investigation of PAH emission from pyrolysis of Chinese coal; PAH production reached a peak
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at around 800⁰C. They were also able to conclude that the lower temperature PAH emission were
already present in the coal 4.

Figure 2.1. Pyrosynthesis of PAHs starting with ethane.
Ravindra et al. (2008) suggested through review that low hydrocarbons such as ethane are
able to form PAHs by pyrosynthesis 3. They noted that when temperatures get as high as 500⁰C
the carbon-hydrogen and the carbon-carbon bonds are broken to form free radicals. These radicals
can then bind with other compounds during the process are then able to combine to form aromatic
rings which are now resistant to further thermal degradation.
Ravindra et al. (2008) further concluded in their review for three mechanistic approaches
for PAH formation during combustion 3. PAH formation could happen through slow Diels-Alder
condensation reactions, rapid radical reactions, and ionic reaction mechanisms. It was later
suggested that the radical formation mechanism was the favored mechanism because of the
combustion process happens rapidly 3.
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The United States Agency for Toxic Substances and Disease Registry (ATSDR/US) has
considered 17 PAHs to be priority PAHs, seen in Table 2.1

3,8

.

Table 2.1
ATSDR/US Priority PAHs, and Phase Distribution 3,8

PAHS
Acenaphthene
Acenaphthlene
Anthracene
Pheanthrene
Pyrene
Benz[a]anthacene
Chrysene
Benzo[b]fluoranthene
Benzo[j]fluoranthene
Benzo[k]fluoranthene
Benzo[a]pyrene
Benzo[e]pyrene
Fluoranthene
Flourene
Dbenz[a,h]anthracene
Benzo[g,h,i]perylene
Indeno[1,2,3-c,d]pyrene

Particle/gas phase
distribution
Gas phase
Gas phase
Particle gas phase
Particle gas phase
Particle gas phase
Particle phase
Particle phase
Particle phase
Particle phase
Particle phase
Particle phase
Particle phase
Particle gas phase
Gas phase
Particle phase
Particle phase
Particle phase

The pre-dominate sources of the PAHs are motor vehicles and wood smoke. Although no
single PAH is exactly like another PAH, it is suspected that these selected priority PAHs are more
harmful and are exemplified through other PAHs. Another reason why these are chosen as priority
PAHS is because there is a greater chance for human exposure than the exposure of other PAHs 3,
8

. A few methods have been developed to assess the amount of PAHs absorbed by the body and

possibly distributed to different organs and tissues. Of the methods, the most widely used is a urine
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test. The urine test looks for low to high levels of 1-hydorxy pyrene. This test is not recommended
to the public, but for those with high risk exposure occupations 7.
2.1.1 PAHs of interest in this study. Figure 2.2 shows the structure of the PAHs of
interests. These PAHs were chosen from lowest to increasing aromaticity. Naphthalene is the PAH
many people smell when using moth balls (it is the main ingredient found in mothballs). It is
composed of two fused benzene rings, making it the smallest PAH.

Naphthalene

Anthracene

Pyrene

Figure 2.2. Three PAHs of Interest.
Naphthalene is the most soluble compound in water (addition of more benzene rings
decreases aqueous solubility of other PAHs) 7. Naphthalene is classified as a possible human
carcinogen and its presence in both internal (homes) and external (outdoors) environment
captivated the interest of this thesis. Naphthalene is ubiquitous in the environment mainly due to
the burning of biomass, gasoline and oil combustion, use of mothballs and also tobacco smoking.
In addition, naphthalene is also used as an intermediate during the production of phthalic
anhydride, surfactants and in pesticides which the US collectively produces about 107,000 tons a
year of naphthalene 9. Because of its vapor pressure of about 0.087 mmHg at room temperature
(25⁰C) it is the most volatile PAH 9. Exposure to this toxic chemical of concern has already been
linked to a number of adverse health effects 9. Some of the health concerns associate with
naphthalene include but are not limited to hyperplasia (respiratory epithelium) and metaplasia
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(olfactory epithelium) and nasal tumors and cancer 9. Naphthalene can also cause the breakdown
of red blood cells if inhaled or ingested in large amounts 7. Since as early as 1980, it has been
reported that naphthalene has been a subject of exposure and risk assessment because of the
negligible health effects. In most recent years, naphthalene was classified as a possible human
carcinogen due to the laboratory assessment of cancer in rats. Its formation, as well as the
formation of other PAHs, has been studied with much rigor. It is determined that combustion is its
largest emission supply. When formed through combustion, 90% of the naphthalene was in the
vapor phase. Interestingly, food cooking can involve the pyrolysis and pyrosynthesis of
naphthalene, researchers have reported that 0.25 micrograms per cubic meter of excess
naphthalene concentrations of fried fish and pork chops while boiling contributed to lower
concentrations being distributed. Another constant supply is through pesticides 9. The major source
of human exposure is through inhalation. Most of the outdoor inhalation is a result of the
combustion of coal, wood and vegetation

10, 11

. Second hand smoke is another major source of

inhalation. Indoor inhalation is via open fireplaces, moth repellent and burning of incense sticks 9.
More generally, naphthalene is used a moth fumigant to repels animals and insects in closets and
other spaces. Napthalene is also used as a deodorizer and toilet refresher. As a result it is to inhale
and come into contact with indoors 9, 10. Naphthalene can attach to clothing and as a result can be
a direct irritant to through skin irritant. It can also be ingested through both contaminated, grilled
and fried foods 9. Extensive research has been done on naphthalene, but little to no research has
focused on human serum attachment and transport. Neither has much research been conducted on
the cellular uptake and toxicity of naphthalene on triple negative breast cancer cells.
Anthracene is a polycyclic aromatic hydrocarbon consisting of three linear fused benzene
rings as shown in Figure 2.2. Like many other PAHs, anthracene is used to make dyes, plastics
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and pesticides. It has also been used to make smoke screens 13. Anthracene and its derivatives are
emitted from some of the same sources as all other PAHs. This includes but not limited to
combustion of coal, coal tar, emission of fuels and oil seepage. Like naphthalene, anthracene is
also found iin cigarettes and tobacco, therefore, one can be exposed through the inhalation of
secondhand smoke. Eating grilled food is another source of anthracene exposure (combustion of
charcoal). Anthracene is classified as one of the seventeen priority PAHs by the United States
Agency for Toxic Substances and Disease Registry. This due is to the abundance of anthracene
and its derivatives found throughout the environment

1-7,16

. It has been suggested that once

anthracene enters the body it tends to target the skin, lymph system, stomach and intestines 16.
Pyrene is a polyaromatic hydrocarbon consisting of two pairs of linear fused benzene rings
stacked on each other as shown in Figure 2.2. Amongst being present in combustion processes,
pyrene is used in to manufacture pigments. While much research on the purest form of pyrene have
not been investigated in detail, much research on pyrene containing PAHs has been investigated.
These compounds along with pyrene itself have proven to be very toxic and carcinogenic to the
human population. Because of its ubiquities in nature, pyre is also listed amongst the 17 US EPA
priority PAHs 1-7. Minimum research has been done to focus on the practical modes of transport
via biological specimen. Also, no research to date has been shown in the toxicity of the compounds
to triple negative breast cancer.
2.2 Human Serum Albumin and Bovine Serum Albumin
Human serum albumin and bovine serum albumin are major biological proteins. Human
serum albumin (HSA) found in the plasma. The typical concentration found in the plasma is about
3.5-5g/100ml

17-18

. Human serum albumin is an anionic, hydrophilic protein with three major

binding regions which will be discussed throughout this section. The protein’s molecular weight
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is about 66,500 Daltons. Like many other important proteins found in the human body, HSA is
synthesized in the liver 18. Human serum albumin (HSA) has a wide affinity for a variety of things
including metals such as copper and zinc, fatty acids, amino acids, metabolites and many drug
compounds. These are many of the reasons why HSA is of great pharmacological and biomedical
interest. One of the most important physiological roles of the albumin is to deliver these solutes to
the bloodstream and to their suggested target organs. Serum albumin is also important for pH and
osmotic pressure maintenance of the plasma. Since as early as the 1970s, many scientists and other
investigators have attempted to use the protein as a carrier to deliver specified drugs 17, 19-23.
Human serum albumin is known to be a single polypeptide amino acid sequence consisting
of 585 amino acid residues. HSA has 17 pairs of disulfide bonds and one free cysteine. HSA in its
monomeric form contains three domains (they are known as domain I, II and III) composed of
alpha-helices. In other words, the amino acids of the protein are arranged in a helical format where
there is little to no free space on the inside and the side chains are pointed towards the outside.
This conformation is usually supported/stabilized through hydrogen bonding 20. Each of the three
domains contain ten helices. These helices are broken in to two groups, A and B. Group A contains
six helices and group B contain four helices. Groups A and B are anti-parallel to one another in
each of the three major domains
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.Over the last 40 years, many biomedical researchers have

gravitated towards understanding the nature of the binding sites on the protein 20. Several crystal
structure analyses have revealed that many binding sites, especially those of drugs are found in
subdomains IIA and IIIA 21. Domain IIA presents a large hydrophobic pocket. While it is known
that subdomain IIA and IIIA are similar topologically similar, in that they are composed of the
same six-helices and hydrophobic pocket/cavity which has distinguishable polar attributes. Several
crystal forms of HSA were studied and reported in the early 1970s 17 19. During this time there was
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not much structural information provided about the protein because of the poor crystal
reproducibility. In the late 1980s through the late 1990s, carter and coworkers along with another
group were able to produce crystal structures of the protein make it better for the structural features
of the protein to be understood. Also, it shed light to the three–dimensional structure which
clarified how the protein-molecule interactions of many drugs, metabolites and potential
environmental contaminants 17. It is necessary in the biomedical and pharmacological community
to understand the binding and transport functions of HSA to provide necessary therapies and
treatments to biological systems. Figure 2.3 gives a more detailed representation of HSA
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.

Because of the three fluorescent amino acids, tryptophan, tyrosine and phenylalanine (these
compounds are fluorescent due to the conjugation), we were able to observe the fluorescent and
identify the binding affinity of PAHs to this protein.

Figure 2.3. Three-dimensional structure of HSA and BSA 24.
Bovine serum albumin (BSA) (Figure 2.2.1), like HSA is a biological protein. This protein
is one of the most abundant found in the cow serum. It differs from HSA in many ways. One of
the main differences is that BSA has two tryptophan amino acids 21, 26-29. One is located in domain
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IA (amino acid 135) and the other is located in domain IIA (amino acid 212). For this cause both
domains IA and IIA are the two major binding sites of this protein 18, 21, 26. Bovine serum albumin
has a molecular weight of about 66,500 Daltons. It used and studied for many of the same reason
as discussed with HSA.
2.3 Cell Cycle, Cancer, Triple Negative Breast Cancer
While it is extremely pharmacologically important to understand how PAHs bind to both
human and bovine serum albumin, we must take into account with how these particular compounds
interacts with human cells. In collaboration with Dr. Checo Rorie (Biology Department, NCAT)
the interaction of PAHs with triple negative breast cancer cells (TNBC) was investigated. Before
advancing further into detail on the focus of the PAH-cell interaction, it is imperative to have an
understanding of the cell cycle and cancer (specifically triple negative breast cancer).
A cell is classified as the basic unit of life and can only arise from pre-existing, living cells.
In other words, cells do not just magically appear. To be more specific, this study focuses on
human breast cells. Like all human cells, these cells must go through the cell cycle. Many scientists
agree that there are two phases of the cell cycle, interphase and mitosis as shown in Figure 2.4.
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Figure 2.4. A brief overview of the cell cycle. Interphase and mitosis are the major components
thereof 30.
In the first phase of the cell cycle, interphase, it is further broken down into three distinct
periods (some may consider it as four periods if they consider growth period zero). During the
first growth period, the cell maintains growth and metabolic roles. This is usually the longest of
them all. This period is the period where the cell is living its normal life 30. During this period of
maintaining its metabolic roles, the cell is said to be fulfilling its purpose in life. For example, if it
is a white blood cell, it is fighting off infections. However, at some point during the cells lifetime,
it has to make the decision to divide 30. Once this decision is made by the cell it enters its first
check point (from now on these check points will be referred to as stop lights). It is very important
that the cell stops at the stop light. While at the stop light the cell is given time to check itself for
any malfunctions and mutations 30. If the cell recognize that something is not right the cell will fix
it with its repair enzymes. Sometimes the cell cannot fix the problem, so in a healthy individual,
the cell will kill itself via apoptosis and will not move on to the next period. Once the cell has
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repaired itself and have the go ahead, it then advances to the next period. This period (S-period) is
referred to the synthesis period. During this period, the cells goes through deoxyribonucleic acid
(DNA) replication 30. After DNA replication the cell goes sees another stop light. If it cannot repair
anything that is it sees wrong it goes through apoptosis. However, if it repairs the inconsistencies,
it to the last period of interphase. This period is known as the second growth period 30. During this
period the cell is awaiting to advance to mitosis. During the second growth phase, the cells are
making the last organelles necessary to advance to cell division. Once it is has succeeded at the
stop light the cell is now ready to undergo mitosis (also known as cell division). There are four
steps that happens before a cell successfully undergoes mitosis as shown in Figure 2.5.

Figure 2.5. The four primary stages of mitosis 31.
The very first step is prophase. During this step the cell has now full committed to
undergoing division. At this point, the nucleolus has now disappeared. The genetic material has
now become loosely coiled (known as chromatin). Mitotic spindles begin formation as centrioles
are moving to opposites sides of the cell. During the second step, metaphase the chromosomes and
the centromeres begin to line along the equatorial plane of the cell (many biologist refer to this as
the metaphase plate. This aid the cell in ensuring that when these chromosomes are separated, each
nucleus will get a copy of each. During anaphase, which is the third step in mitosis, each pair of
chromosomes are now separated and are pulled to opposite ends of the cell via the microtubules
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(microtubules degrade after this). During the last step in mitosis, telophase, new membranes begin
to form around the prospective organelles. It is also important to note at this point the chromosome
spread is not noticeable. Toward the end of telophase one will notice that there are two copies of
all organelles and also two cells that have not yet been detached. At this point the cell goes through
cytokinesis where the cell membranes are separated. Cytokinesis is a separate process from
mitosis, though many will include it with telophase. This is a result of the process beginning the
same time as telophase and ends upon the completion of telophase.
The description above is how a normal, healthy cell were to behave under normal
conditions. When cells do not operate according to how they should, many diseases including
cancer may develop. Cancer is known to many as one to the most terrifying ailments to deal with.
Cancer is a result of the cells passing the stop light during the cell cycle. Instead, these cells
metaphorically put their feet on the gas pedal and go through rapid and uncontrolled cell
proliferation. There are seven hallmarks of cancer which is shown in Figure 2.6.
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Figure 2.6. Illustration of the seven hallmarks of cancer 32.
In no particular order, one of the hallmarks of cancer is self-sufficiency in growth signals.
In normal cells, growth occurs upon expression of growth factors. In most cancer cells there is an
overexpression of these growth factors. Another hallmark of cancer is the insensitivity to antigrowth signals. The cancer cells no longer have receptors for the anti-growth factors it is presented
with so they are unable to recognize and respond to it. Another hallmark of cancer is the tissue
evasion and also metastasis. This could be broken into different hallmarks. One of the most
common hallmarks of cancer is limitless replicative potential. Once cancer is more advanced in its
stages (stages of cancer will be discussed later in this section) it begins angiogenesis. In laymen
terms, the cancer now has generated/created its own blood supply. The last hallmark of cancer is
evading apoptosis. That is some cancer cells has the ability to ignore signals to kill itself 33. Many
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oncological professionals warn that if one of the hallmarks of cancer are present, then one could
have cancer. A person does not have to exhibit all of the hallmarks of cancer because every
biological system responds differently.
Modern day medicine and therapies have advanced significantly to ensure that that those
living with cancer are able to manage it. Some of the treatment options for cancer is dependent on
the overall health and preference of the patient. Treatment options include, chemotherapy,
immunotherapy, and targeted therapy to name a few. These options are also dependent upon type
and progression of the cancer. There are five stages of cancer. Stage 0 is known as in-situ cancer.
At this stage, the cancer is in place and have not invaded any of its nearby tissues. During this
stage the cancer is said to be curable. This is because the cancer could easily be removed by simply
removing the tumor. Stage I is known as localized cancer, also It is most notably referred to as
early-stage cancer. The cancer has not yet invaded deep into the tissues or reached the lymph
nodes. During stages II and II the tumor have now grown more vastly into the nearby tissues. At
this point angiogenesis has now begun and the cancer has spread to the lymph nodes. Lastly, stage
IV is the most malignant form of cancer. At this point, the cancer have now spread throughout the
rest of the body and now begun attacking other tissues and organs (this is known as metastasis) 33.
This is the most difficult type of cancer to treat.
People are diagnosed with various types of cancers in the United States alone. Figure 2.7
illustrates many of the different types of cancer found in both men and women. Table 2.1 shows a
more statistical view of cancer and its statistics as it relates to the most prevalent cancers and deaths
in the USA.
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Figure 2.7. Types of cancers found in both men and women 34
Table 2.2
Estimated New Cases of Cancer and Cancer Deaths in 2014 35

Type
Prostate
Lung and bronchus
Colon and rectum
Breast
Lung and bronchus
Colon and rectum

Estimated New Cases and Deaths
Male
Number of Cases (thousand)
233
116
71.83
Female
232.67
108.21
65

Deaths (thousand)
29.48
86.93
26.27
40
72.33
24.04

Age, race, diet, genetic, and gender are among the major risk factors of a person getting
cancer in his or her lifetime. The focus of this thesis is the investigation on TNBC cells. Breast
cancer is the most common type of cancer a female is diagnosed with in the United States. As
Table 2.2 suggests, an estimated 232,670 women were diagnosed with cancer in the year 2014. Of
the women diagnosed with cancer an approximate 40,000 died of breast cancer. There are many
forms of breast is more than one form of breast cancer, however this study focused on TNBC cells.
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Triple-negative breast cancer is a more recently coined term in the medical and scientific
community. It was first mentioned in 2005 but ever since then it has been mention in nearly 1,000
publications. This is a result of increasing interest by health and other professionals because of the
12% to 17% of women with breast cancer who have triple negative breast cancer 36. Treatments
are not as readily available for women with this type of breast cancer. Triple-negative breast cancer
is the only type of breast cancer that lack expressions of the estrogen receptor (ER), progesterone
receptor (PR), and the human epidermal growth factor receptor type 2 (HER2) 36-39. Triple negative
breast cancer occur more frequently in young black and Hispanic women than those of other racial
or ethnic groups

36

. Approximately 20-40% of African American women diagnosed with breast

cancer have triple-negative breast cancer 38. Doctors use the same types of tests, treatments and
surgeries for possible treatment of triple negative breast cancers as they do for other types of breast
cancers. The treatment for those diagnosed with this form of breast cancer is chemotherapy. This
is a type a medicine that kills cancer cells everywhere in the body 38. However, it is very important
to note that this type of treatment is called systemic, meaning that it is a whole-body therapy.
Therefore, this therapy is killing off a majority of the cancer cells, it also kills some of the healthy
cells as well which may cause one to feel pain, sickness, and fatigue. Medical and other oncologic
professionals are making every effort to encourage women to have thorough breast examinations
and also check for mutations in one of the two genes (BRCA1 and BRCA2) as it may very well
increase the risk of a her developing breast cancer in her lifetime 38.
The p53 tumor suppressor gene was first recognized in 1979 as the transformation-related
protein that accumulates in the nuclei of cancer cells
family: p53, p63, and p73

40

40

. It belongs to a three member protein

. They are all structurally and functionally related, however, it was

noticed that in the higher organisms, the p53 has evolved to prevent (suppress) tumor development.
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The p63 and p73 had major roles in functioning normal cellular development. The p53 protein is
found on chromosome 17 and is made up of a 393 amino acid sequence. It has several structural
and functional domains. A few years after this identification it was recognized that this wild type
p53 protein had no oncogenic properties of the cell. It was not until the early 1990s that a mutation
of p53 was discovered and classified as a gain of oncogenic function 40. It was then noticed that
the wild type p53 protein was the major guardian of the genome. That is the p53 protein contributed
to many vital functions of the human system. It is responsible for cell cycle regulation, the
induction of apoptosis, and genomic integrity.
As a tumor suppressor gene, one of the major physiological functions of p53 is to prevent
unwarranted cell proliferation. Activation of p53 occurs after an intracellular or extracellular
stimuli has caused damaged. This damage includes an array of factors such as UV radiation and
cytotoxic chemicals and drugs. Once activated, p53 can induce cell cycle arrest. Cell cycle arrest
could happen in any of the phases associated with interphase. By induced cellular arrest the p53
gene is given the cell additional time to repair any genomic damage. For this reason p53 is known
as a cellular gatekeeper. As a gatekeeper, it monitors cellular stress and can also induce apoptosis
if necessary. Figure 2.8 gives a structure of the three proteins with major emphasis on the p53
protein.
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Figure 2.8. The functional domains of the p53 protein. 41
The central region of the p53 protein is extremely hydrophobic and is a sequence-specific
binding domain for damaged DNA. The p53 protein can be activated by in a variety of ways. One
mode of activation is through phosphorylation from protein kinases

40

. Lack of the p53 gene

activation is known to play a role in all types of cancers and is associated with more than 50% of
all cancer cases worldwide 40.
As previously mentioned, once activated p53 can cause cell arrest or apoptosis. Apoptosis
is a term coined to describe programmed cell death. Apoptosis is a distinctive form of cell death
42

. Apoptosis occurs in normal cell development as mechanism to maintain cell growth. It is also

used as a defense response when cells are damaged by disease and other toxic concoctions. Whilst
there are both pathological and physiological stimuli that may induce apoptosis, not all cells will
die via the same stimulus. DNA-damaged cells die via a p53 dependent pathway of apoptosis,
while other cells are unaffected 42. The apoptotic pathways of cell death is very sophisticated and
complex. Two of the major apoptotic pathways are the extrinsic (death receptor) pathway and the
intrinsic (mitochondrial) pathways 42. Figure 2.9 gives a general diagram of how the p53 protein
engage in the apoptotic cycle.
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Figure 2.9. p53 role in the intrinsic pathway of apoptosis 43
The p53 dependent apoptotic pathway is a form of the intrinsic pathway. Cellular stressors,
such as DNA damage, stabilize and activate the p53 protein by activation 43. The stabilized forms
of p53 accumulates in the nucleus and cytoplasm of the stressed cells and regulates the expression
of the pro-apoptotic genes that are directly associated with inducing mitochondrial outermembrane permiabilization. Once this happens an apoptosome formation is initiated and a cell
death cascade is activated 43.
2.4 Fluorescence
Luminescence comes from the Latin root lumen which means light

44

. In 1888, Eilhard

Wiedemann came up with this term to describe the phenomena of light that is not incandescence
(conditioned by the rise of temperature). The present day definition of luminescence is “a
spontaneous of emission of radiation from an electronically excited species (or from a vibrationally
excited species) not in thermal equilibrium with its environment”

44

. In more simple terms,

luminescence can be defined as the “transformation of diverse modes of energy into a form of
visible light” 44. There are nine different types of luminescence. They are classified according to
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their mode of excitation. The type of luminescence that was focused on for purposes of this thesis
paper was photoluminescence.
Photoluminescence can be defined as the production of light “from the direct
photoexcitation of the emitting species” 45. Photoluminescence is divided into three sub-groups:
(1) fluorescence, (2) phosphorescence and (3) delayed fluorescence. The term fluorescence was
first introduced by G.G. Stokes in the mid-nineteenth century. At this point in time the distinction
between fluorescence and phosphorescence was that fluorescence was the emission light that
disappears simultaneously at the end of excitation. Whereas with phosphorescence, the light
emitted will persist for some time even after excitation

45

. After the discovery of delayed

fluorescence, those distinctions became inadequate. Molecular photochemists now say that spin
multiplicity is retained for fluorescence, however, phosphorescence would involve a change in
multiplicity usually from singlet to triplet or vice versa (shown in Figure 2.10) 45.

Figure 2.10. The simplified Perrin-Jablonski Diagram. Non-radiative decay is not shown in
figure.
In the simplified Perrin-Jablonski diagram (see Figure 2.10), the distinction between
fluorescence and phosphoresce. In the diagram the electron are excited (absorb the energy,
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absorption spectrum), after excitation the electron loses its energy either through radiative
relaxation (emits light, emission spectrum) or non-radiative relaxation (does not emit light, not
pictured). Since the purpose of this thesis did not focus on phosphorescence, the rest of this section
will focus primarily on steady state fluorescence. The period where the fluorophore is absorbing
energy (or when the electron is excited) is when the electron in the lowest unoccupied orbital
(better known as the LUMO) is being shifted to the highest unoccupied molecular orbital (HOMO).
Fluorescence typically occurs from aromatic molecules. The first known fluorophore was quinine.
Quinine played a key role in the development of the spectrofluorometers in the 1950s 46.
As seen in Figure 2.11, after an electron is excited (period of absorption) it is rapidly rotates
downward to the next electronic sub-stable level (kasha’s rule). This is known as internal
conversion. It should be noted that excitation happens very rapidly (~10-15 seconds). Internal
conversions happens in as little as ~10-13 seconds. After internal conversion, during fluorescence
the electron experiences both non-radiative relaxation (no emission as it travels to the ground state
(this is not pictured). and also radiative fluorescence (emission of light). This is said to happen as
quickly as ~10-9secs. It should be noted that these times are were taken from one source 47. The
author did make a note that there were minor variations of time throughout the scientific
community. The time for the electron to reach its stable state (S0) is relatively faster in fluorescence
than that of phosphorescence (said to happen anywhere from 10-3-10 seconds). This has to do with
the intersystem crossing (shown in Figure 2.11). During intersystem crossing the electron is going
from a singlet stat to triplet state, to get back to the stable singlet state (S0) 47.
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Figure 2.11. Jablonski’s diagram of fluorescence. Legend to the right gives brief description.
Non-radiative decay not shown in figure.
The Jablonski diagram is named after Professor Alexandar Jablonski and he is regarded as
the father of fluorescence because of his many contributions to the field

46

. While Jablonski’s

diagram of fluorescence gives us a great idea of adsorption and emission of light, it also gives
some generalization of what to expect when observing different fluorophores. Upon adsorption of
light, flourophores, tend to emit light at longer wavelengths. This is known as a red shift (Stokes
shift) 44-45. This could be easily explained through use of the Figure 2.11. Once excited, the electron
then experiences internal conversion. A red shift is described in general chemistry as the point
when energy shifts from shorter wavelength toward longer wavelengths (toward the red region of
the visible spectrum). Having longer wavelengths would result in the decrease in frequencies thus
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having lower energy. This is what happens during internal conversion. If the electron is excited to
the vibrational and rotation region, it will rotate and vibrate down to the next sub-stable state via
Kasha’s rule 44. Therefore, the electron will be emitting light at a lower energy than it had absorb,
resulting in the red (Stoke’s or Bata chromic) shift.
It is also important to understand the principles of measuring fluorescence. Figure 2.12
gives an illustrated overview of fluorescence measurement.

Figure 2.12. Instrumentation, measuring fluorescence
First the polychromatic light (our light source) goes through a monochromator (prism). The
first monochromator is responsible for the excitation wavelength. This monochromator will only
allow the wavelength chosen to shine through to the sample. Once the wavelength hits the samples
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there is a 90⁰ turn which make the fluorescence more sensitive than UV absorption. Once the
monochromatic light shines through the sample the fluorescence given off through the sample goes
through a monochromator responsible emission wavelength. This monochromator will allow the
emission wavelength chosen to shine through to the detector. The detector will supply the reading
47

. Fluorescence is now one of the most used methodologies in an array of biomedical and

biotechnology studies 46.
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2 CHAPTER 3
Methodology
3.1 Sample Preparation
Acid 3-morpholino-propanesulfonique (MOPS) buffer, HSA, BSA, naphthalene,
anthracene, pyrene, dimethyl sulfoxide (DMSO) and acetonitrile were purchased from SIGMAALDRICH Company. Sodium hydroxide was purchased from Fisher-Scientific Company.
Throughout the whole project 30M MOPS buffer solution was used. The pH of the buffer solution
was adjusted to 7.4 (physiological pH) sodium hydroxide solution. The buffer solution was stored
in the refrigerator for 24 hours before use.
Approximately 0.025% solutions of HSA and BSA were prepared using MOPS, 7.4 buffer
solution. Upon preparation, these protein solution were store in the refrigerator for a minimum of
48 hours to ensure activation. It is also important to note that none of the protein solutions were
used pass twenty days to ensure protein activity.
Stock solutions of analytes (naphthalene, anthracene, and pyrene) were made using solvent
acetonitrile. This solvent was used for spectroscopic results. All of the solutions were made so that
the PAH concentrations were 1.00×10-03M. All stock solutions were stored in the refrigerator for
at least 24 hours before use.
The PAHs were titrated, using eppendorf pipets, into HSA/BSA solutions and buffered to
the 3 ml mark. While naphthalene concentrations ranged between 2.00×10-06M and 1.40×10-05M,
while anthracene concentrations ranged between the values of 2.00×10-06M and 6.60×10-05M. The
pyrene concentration ranged between 8.00×10-07M and 1.28×10-05M. All samples including
control (HSA/BSA and buffer mixed only) and blank (buffer only) were equilibrated at room
temperature for at least 1 hour to ensure protein-analyte interaction. The samples were subjected
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to fluorescent and ultraviolet-visible measurement using Spectrofluorometer (Jasco-8500) and
Shimadzu UV-Vis NIR Spectrophotometer respectively.
3.2 Ultraviolet-Visible (UV-Vis) Spectroscopy
Different molecules can absorb different wavelengths of light. Since the proteins of interest
(BSA and HSA) absorb in the UV-Vis region, UV-Vis spectroscopic techniques was used for the
study. The visible of the electromagnetic region ranges from 400 nm to 780 nm. The ultraviolet
region of the electromagnetic region ranges from 200 nm to 315 nm. For ultraviolet-visible (UVVis) spectroscopy, a Shimadzu UV-3600 UV-Vis NIR Spectrophotometer was used collect all
data. Data was collected for all of the protein-analyte complexes at five different temperatures;
25⁰C, 37⁰C, 45⁰C, 55⁰C, and 65⁰C. UV-Vis main purpose was to obtain the absorbance of HSA
and BSA. The lambda-maximum of the tryptophan residue(s) in the proteins were used for
excitation wavelength when doing fluorescence. Questions were raised because some thought
tyrosine was in this region, but this question was justified through internal fluorescent quenching.
Also, by using this spectroscopy, the energy transitions (transitions will be discussed further in
results and discussion) of the samples were determined. The blank used for protein-analyte
complexes was MOPS buffer. To get a general scheme of where the analytes absorption took place,
acetonitrile was as the blank. The results of these studies were used to accurately determine the
concentrations of HSA and BSA, using equation 4. The concentration of BSA for this study was
1.3 × 10-06 M, and 2.5× 10-06 M for HSA.
3.3 Fourier-Transform Infrared (FTIR) Spectroscopy
For FTIR data collection, a Shimadzu IR Affinity-1 FTIR Sectrophotometer was used.
Solid samples of all proteins and analytes of interests were used to get results. Enough of each
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solid sample were placed on top of the red crystal (the crystal was completely covered). All
backgrounds were ran at resolution four, from 300 cm-1 to 4000 cm-1.
3.4 Fluorescent Spectroscopy and Calculations
All fluorescent data were collected using a Jasco Spectrofluorometer JP-8500. The samples
were excited at 280 nm and the emission of the samples were collected between 285 nm and 550
nm. A 1 cm cuvette was used in all experiments. Scan speed was typically at 200 nm/minute at
high sensitivity with emission and excitation bandwidths of 2.5 nm.
3.4.1 Determination of binding association constant and stoichiometry of PAHHSA/BSA complexes. The binding constants and stoichiometry were determined by using the
modified Stern Volmer equation shown in Equation 1.

𝐹 − 𝐹0
log (
) = log 𝐾 + 𝑛 log[𝑃𝐴𝐻]
𝐹0

Equation 1. Modified Stern Volmer equation

F is the final fluorescent intensity which is the intensity after the protein (HSA or BSA)
has been exposed to naphthalene, anthracene and pyrene. Fo is the initial fluorescent intensity of
the protein only. K is the binding constant and n is the stoichiometry Also, [PAH] is representative
of the concentration of the PAHs.
3.4.2 Determination of thermodynamic property of PAH-HAS/BSA complexes.
Thermodynamic parameters were also calculated to determine the types and feasibility of bonding.
These parameters were calculated using the Van’t Hoff equation shown in Equation 2.

∆𝑆 −∆𝐻 1
ln 𝐾 =
+
𝑅
𝑅 𝑇

Equation 2. Van’t Hoff equation
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Where K the binding constant, ∆S is the entropy of the protein-analyte complex, and ∆H
is the enthalpy. T is the temperature in Kelvin. R is the ideal gas constant. The Gibbs free energy
(∆G) was calculated using Equation 3.

∆𝐺 = ∆𝐻 − 𝑇∆𝑆 − 𝑇∆𝑆

Equation 3.Gibbs free energy equation
3.5 Investigation of PAHs on Triple Negative Breast Cancer: Protocol and Sample
Preparation
The human breast cancer cell lines were purchased from American Type Culture Collection
(Manassas, VA). HCC1806 is a basal cell line that expresses the triple negative phenotype which
is a result of the lack of expression from progesterone receptor (PR), estrogen receptor (ER) and
human epidermal growth factor 2 (HER2) receptor. This cell line was derived from a 60 year old
African-American woman on July 31, 1995.

She suffered from a primary squamous cell

carcinoma. The tumor was considered to be a grade 2 tumor. MEGM bullet kit growth media,
soybean trypsin inhibitor, 5 ml pipets and 10 ml pipets, and tissue/cell culture plates were all
purchase from Fisher-Scientific Company. Upon 80% confluency of TNBC they were ready to be
exposed to the PAHs of interests (naphthalene, anthracene and pyrene).
The first thing done to prepare was the placement of growth medium in 37⁰C water bath.
After this, pre-treatment pictures of the cells were taken with a microscope at magnification 10X
and 20X. With a total of thirteen cell cultured plates. Concentrations used for all three PAHs were
the same (1.8×10‾5M, 2.5×10‾5M, 3.6×10‾5M). Standard cell plates of each concentration using
dimethyl sulfoxide (DMSO) were made to compare results with results of those cells treated with
PAHs. Stock solutions of PAHs were made using DMSO instead of the acetonitrile. Preliminary
studies showed that acetonitrile is very toxic to TNBC cells. Old media and non-adhesive cells
(apoptotic cells) were extracted from each of the thirteen cell plates. Known concentrations of
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PAHs were titrated into each of the plates and buffered with medium to obtain a total volume of 2
mL. One of the thirteen plates were just treated with the medium (no other chemicals were added)
this was done so that we could compare DMSO damage to cells. Treated cells were placed back
in the incubator for 24 hours. The incubator was at appropriate temperature and gas mixture (37⁰C
and 5% CO2).
After 24 hours incubation period pictures were taken of each plate (shown in results) at the
same magnifications previously described. After completion of picture taking, a cell viability stud
of all plates containing concentration of 2.5×10‾5M of the PAH, the untreated cells, and the control
(DMSO). The very first step in cell viability preparation is the collection 2 eppendorf tubes per
cell plate and 1 conical tube per sample plate. Tubes were labeled according to cell plate label. A
major aspect of the process is to keep the volume low. Since bigger sized cell plates were used, it
was very important that conical tubes did not exceed 5 mL final volume. Secondly, media and
apoptotic cells were removed and placed into the corresponding conical tube (this is about 2 mL).
Next, 1 mL of phosphate buffered saline solution (purchased from Fisher-Scientific Company) and
gently swirled. Solution-along with any of the residual media-was to conical tubes (conical tubes
contain 3mL total volume). Addition of trypsin-ethylenediaminetetraacetic (EDTA) to the plates
were allowed to 5-15 minutes. The trypsin-EDTA is responsible for chelation and is used to detach
the living cells from the plate. During the process of incubation, 10 microliters of trypan blue were
added to each labeled eppendorf tubes. The trypan blue is responsible for coloration of the dead
cells. After all of the cells detached from the plates (a slight finger tap to ensure cells have lifted),
splashing technique was use to prevent reattachment to the cell plate. After this, all contents were
transferred to conical tubes (all have 5 mL total volume). Conical tubes were inverted several times
and immediately transferred to the two of the appropriately labeled eppendorf tubes (10
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microliters). Eppendorf tubes were vortexed for approximately 20 seconds and 10 microliters were
transferred to one of two sides of the cell counting slides. A total of 2 eppendorf tubes were used
per counting side (1 eppendorf tube per side). Each side of the cell counting slide was placed into
the counter and data was reported.
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3 CHAPTER 4
Spectroscopic Results
4.1 FTIR Study
FTIR study was used to identify the major functional groups of the HSA and BSA.
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Figure 4.13. FTIR Sprctra of HSA and BSA

Figure 4.14. FTIR Spectra of Naphthalene, Anthracene, and Pyrene
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Figure 4.15. FTIR Sprectra HSA, BSA, and Naphthalene
100
HSA

% Transmittance

95
90

Anthracene

Amide 1
~1645 cm-1

85
80
75

BSA

Broad O-H
~3298 cm-1

Amide 2
~1507 cm-1

3700

3200

2700
2200
1700
-1
wavenumber, cm

Figure 4.16. FTIR Spectra HSA, BSA, and Anthracene

1200

700

39

100
95

% Transmittance

90
85

Broad O-H
~3298 cm-1

Amide 1
~1645 cm-1

80
75

HSA
BSA

Amide 2
~1507 cm-1

70

Pyrene

65
60

3200

2700

2200
1700
wavenumber, cm-1

1200

700

Figure 4.17. FTIR Spectra HSA, BSA, and Pyrene
Figures 4.1-5 is the FTIR spectra of the overlaid HSA and BSA proteins, overlaid PAHs,
and overlaid PAH, HSA, and BSA. The broad alcohol stretch is at ~3298 cm-1, C=C—H stretch at
~2900-3000 cm-1, C=C stretch ~1735 cm-1, and C=O stretch ~1737 cm-1. Two amide regions are
located at 1650 cm-1 and 1500 cm-1. This is due to the C=O (amide 1) and the N—H (amide 2)
stretch. There is also C-H bending ~1365-1215 cm-1, C-C stretch ~835 cm-1 and C-H rock ~707
cm-1.
4.2 UV-Visible Spectroscopic Study
A UV-Visible spectra presented in this section were used to accurately determine the
concentration of HSA and BSA. Through successful application of beer-lambert’s law (Equation
4) the concentrations of the proteins were obtained.

Equation 4. Beer-Lambert law
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Where A is the absorbance, e is the molar absorptivity or extinction coefficient in L mol -1
cm-1, b is the path length of the sample in cm, and c is the concentration of the compound (protein
in this case) in solution reported in M.
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Figure 4.18. BSA UV-Vis Absorbance
Bovine serum albumin absorbance is shown in Figure 4.6. The absorbance at λmax 280 nm
is 0.055 units (au). The molar extinction coefficient of BSA is 43,824 L mol-1 cm-1. The

absorbance, a.u.

concentration of BSA for this study was 1.3 × 10-06 M.
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Human serum albumin absorbance is shown in Figure 4.7. The absorbance at λmax 280
nm is 0.097 units (au). The molar extinction coefficient of HSA is 38,553 L mol-1 cm-1. The
concentration of BSA for this study was 2.5 × 10-6M.
Of the three fluorescent amino acids, major focus was on tryptophan. Due to more
conjugation, tryptophan is the lowest in energy so it would be seen at a longer wavelength.
According to research literature, it is understood to have a maximum absorbance at 280nm. At this
absorbance, tryptophan is also internally quenching the fluorescent tyrosine residue.
From previous literature review naphthalene has a broad band in between 250 nm and 270
nm. There was a hypsochromic shift due to the interference of the naphthalene with the tryptophan
and in the presence of the acetonitrile solvent. In reference to tryptophan absorbance in the
presence of naphthalene; as a reminder naphthalene, has a broad band in between 250 nm and 270
nm. Anthracene has a broad band around 260 nm and a secondary broad band at 340 nm. Referring
back to figures mentioned already in this paragraph, there is a hypsochromic shift due to the
interference of the anthracene with the tryptophan. It is evident temperature is in part causing the
hyperchromic effect of this the molecule. Also it is noticeable that as the concentration of
naphthalene is increased, so is the absorbance of my tryptophan region. This is a result of the
anthracene with the tryptophan. UV-Vis did not make it evident. Due to more conjugation, pyrene
absorb at lower energy than anthracene and naphthalene. Pyrene was affected in the same way.
4.3 Fluorescence Spectroscopy (Emission spectrum) for Both Protein-Naphthalene
Complexes
In this section, results of fluorescent spectroscopic measurements are shown between HSAnaphthalene complex and also BSA-naphthalene complex. The proteins go through structural
changes as they are complexed with PAHs. These structures are dependent upon concentration of
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PAH and temperature. Data collected in this section were used to calculate the binding constants
and thermodynamic variables.
3500

fluorescent intensity

3000
2500
2000

25⁰C
37⁰C
45⁰C
55⁰C
65⁰C

1500
1000
500
0
285

335

385

435

485

wavelength, nm
Figure 4.20. General BSA Study at Different Temperatures
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Figures 4.8 and 4.9 are emission spectrum of both proteins (BSA and HSA respectively)
as they are introduced to a variety of temperatures. Increased temperature resulted in a decrease in
fluorescent intensity on BSA and HSA, thus causing the fluorescent intensity to decrease. The
fluorescence of the protein is decreased because of denaturation of the protein. The wavelength of
highest fluorescence was obtained for BSA and HSA. BSA had highest fluorescence at 341nm and
HSA at 335 nm. These wavelengths were used to calculate binding constants, stoichiometry and
thermodynamic variables.
3500

fluorescent intensity

3000
2500
2000
1500
1000
500
0
285

305

325

345

wavelength, nm
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Figure 4.23. HSA-Naphthalene at 37⁰C
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Figure 4.24. BSA-Naphthalene Temperature Comparison at λmax= 341 nm
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Figure 4.25. HSA-Naphthalene Temperature Comparison at λmax= 341 nm
Figures 4.10-13 shows the emission of samples containing fixed BSA and HSA at varying
naphthalene concentrations. The increased naphthalene concentrations resulted in an increase of
BSA and HSA intensity. This is best known as a hyperchromic effect. It also show that
temperature’s major role in fluorescence for this particular cause is through by quenching. A
complexation of naphthalene with BSA and HSA also resulted in a bathochromic shift. Due to
naphthalene bicyclic aromatic characteristics its fluorescence is seemingly in the same region as
that of tryptophan.
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Figure 4.28. BSA-Anthracene Temperature Comparison at λmax= 341 nm
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Figures 4.14-17 indicates anthracene’s hypochromic and batachoromic effect and shift
respectively. As the concentration of anthracene is increased the fluorescence of BSA and HSA
decreases. Because anthracene is a conjugated system, it is expected to see it longer wavelengths
(lower energy) than less conjugated systems (naphthalene in this case). Interaction between
anthracene is observed by the hypsochromic shift in the anthracene region. Increased temperature
had a hypochromic effect in both regions of fluorescence. In Figures 4.16-17 the effect of
anthracene along with the BSA and HSA were further investigated. Due to the complexation, both
proteins go through structural changes.
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Figure 4.32. BSA-Pyrene Temperature Comparison at λmax= 341 nm
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Figure 4.33. HSA-Pyrene Temperature Comparison at λmax= 341 nm
Figures 4.18-21 shows pyrene’s hypochromic effect on BSA and HSA. Figures 4.20-21
shows that as temperature and concentration of pyrene is increased, the intensity of the HSA and
BSA are decreased. Pyrene is known as a quenching agent in the protein region. During
equilibrium period (discussed in methods) pyrene complexes with the protein.
4.4 Determination of Binding Constant and Stoichiometry of PAHs-BSA and PAHs-HSA
Complexes
Binding constants and stoichiometry were accurately determined using the modified Stern
Volmer equation (Equation 1). Wavelengths of maximum fluorescence were 335nm and 341nm
for HSA and BSA respectively. Tables are shown as a comparison of the effects the PAHs have
on HSA and BSA.
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Table 4.1
Comparison of Binding and Stoichiometry on Naphthalene-BSA and Naphthalene-HSA
Complexes

Temperature, Kelvin
298
310
318
328
338

Binding Constant (M -1 )
BSA
HSA
2.65E+01
4.65E+07
9.07E+05
5.20E+07
4.50E+06
1.81E+02
5.16E+06
3.31E+04
5.80E+02
1.91E+04

Stoichiometry
BSA
HSA
0.53
1.694
0.6
1.7001
1.54
0.6202
1.53
0.8444
0.652
1.0133

In Table 4.1, temperature has a major effect to how the naphthalene binds the protein. As
temperature increases, the binding increases in the naphthalene-BSA complex, with exception to
338 K. At this temperature binding could be affected majorly because of structural and
conformational changes due to temperature. The binding for the naphthalene-HSA complex
decreases as temperature is increased. Because of the tryptophan regions in both HSA and BSA,
it was expected that there be a 1:1 and 2:1 molar ratios of naphthalene-HSA and naphthalene-BSA
complexes, respectively. The conformational changes in the protein could be a factor. Current
studies are being done to understand this further.
Table 4.2
Comparison of Binding and Stoichiometry on Anthracene-BSA and Anthracene-HSA Complexes

Temperature, Kelvin
298
310
318
328
338

Binding Constant (M -1 )
BSA
HSA
1.92E+03
4.94E+03
4.25E+02
4.85E+03
8.50E+02
1.08E+04
2.34E+03
1.03E+05
2.58E+03
5.78E+02

Stoichiometry
BSA
HSA
0.86
1.09
0.87
1.14
0.79
1.14
0.89
0.98
0.92
0.94
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In Table 4.2 temperature did not play a role in the binding association of anthracene to
BSA and BSA because the binding constants are relatively the same. The binding affinity of
anthracene to the proteins is relatively high. The stoichiometric ratios of anthracene-BSA and
anthracene-BSA are around 1:1 as temperature is increased.
Table 4.3
Comparison of Binding and Stoichiometry on Pyrene-BSA and Pyrene-HSA Complexes
Temperature, Kelvin
298
310
318
328
338

Binding Constant (M -1 )
BSA
HSA
1.20E+05
1.45E+04
1.12E+05
1.65E+04
2.08E+05
3.14E+05
6.42E+03
1.49E+07
8.47E+04
2.28E+07

Stoichiometry
BSA
HSA
1.12
0.92
1.12
0.94
1.17
1.19
0.9
1.52
1.13
1.58

In the Table 4.3, as temperature increases the binding increases in the pyrene-BSA
complex, with exception to 328 K. At this temperature binding could be affected majorly because
of structural and conformational changes due to temperature. The binding association constant for
the pyrene-HSA complex increases as temperature as temperature. The stoichiometry for pyreneBSA complex is 1:1, temperature increase do not have any major impact. On the contrary, when
pyrene is bound to HSA at 328 K and 338 K, a 2:1 pyrene-HSA stoichiometric ratio was observed.
4.5 Investigation of Thermodynamic Property on PAH-BSA and PAH-HAS Complexes
Table 4.4
Comparison of Thermodynamic Property on Naphthalene-BSA and Naphthalene-HSA
Complexes
Temperature, Kelvin
298
310
318
328
338

∆H (J)
BSA
HSA

∆S (J/K)
BSA
HSA

∆G (J)
BSA
HSA
-2.98E+04 -2.13E+04
-3.11E+04 -2.27E+04
2.18E+03 1.33E+04 1.07E+02 1.16E+02 -3.19E+04 -2.36E+04
-3.30E+04 -2.48E+04
-3.41E+04 -2.59E+04
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In the naphthalene-BSA and naphthalene-HSA complex in Table 4.4, the positive enthalpy
and entropy values indicate that the binding is due to hydrophobicity. The high negative Gibbs
free energy at any moment indicates that the binding of naphthalene to the two protein complexes
is spontaneous.
Table 4.5
Comparison of Thermodynamic Property on Anthracene-BSA and Anthracene-HSA Complexes

Temperature, Kelvin
298
310
318
328
338

∆H (J)
BSA
HSA

∆S (J/K)
BSA
HSA

∆G (J)
BSA
HSA

-1.25E+04
-1.33E+04
1.88E+05 6.43E+04 6.71E+01 8.13E+01 -1.38E+04
-1.45E+04
-1.52E+04

3.88E+04
3.77E+04
3.70E+04
3.62E+04
3.53E+04

In the anthracene-BSA and anthracene-HSA complex in Table 4.5, the positive enthalpy
and entropy values indicates hydrophobic binding. The high negative gibbs free energy at any
moment indicates that the binding of anthracene to BSA is spontaneous. However the to the two
protein complexes is spontaneous. This is not the same for HSA. Because of the high positive free
energy values, anthracene-HSA complexation is not favored. In other words, energy is required
for complexation.
Table 4.6
Comparison of Thermodynamic Property on Pyrene-BSA and Pyrene-HSA Complexes

Temperature, Kelvin
298
310
318
328
338

∆H (J)
BSA
HSA

1.68E+05

7.56E+05

∆S (J/K)
BSA
HSA

9.90E+01

1.29E+02

∆G (J)
BSA
HSA
1.39E+05 7.18E+05
1.38E+05 7.16E+05
1.37E+05 7.15E+05
1.36E+05 7.14E+05
1.35E+05 7.13E+05
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In the pyrene-BSA and pyrene-HSA complex in Table 4.6, like naphthalene and
anthracene, the positive enthalpy and entropy values indicates hydrophobic binding. The positive
free energy indicates this is not spontaneous. This is an endothermic complexation, because of the
energy required.
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4 CHAPTER 5
5

PAH Cytotoxic Effects on Triple Negative Breast Cancer Cells

The protein-analyte complex considerations above were used as a preliminary basis of cell
study. While it is vital to understand how these analytes are interacting with serum and other
transport proteins, it is of great value to understand what is also happening on the cellular level.
The results shown below are the preliminary results.
This section is to focus mainly on cell appearance. All pictures in this section are reported
at 10X magnification. Magnification pictures at 20X were also taken but are not shown. Because
of acetonitrile’s highly toxic effect interactions with cells, dimethyl sulfoxide (DMSO) was used
as the solvent at three different concentrations (the same concentrations of analyte was used).
Pretreatment

Control

DMSO

Control

Control

Control

Naphthalene
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Control

Figure 5.34. Pre-treatment of TNBC cells compared to the Non-treated cells. These results are
them compared to solvent and analyte introduction at 1.8×10-05 M concentration.
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Figure 5.1 shows cellular activity after exposure to the lowest concentration of PAHs. The
solvent had a slight toxic effect on the cells. As the cells were treated with naphthalene, apoptosis
of the cells were induced. Anthracene and pyrene effects were beginning to induce apoptosis. The
cells were aggregating more with anthracene and pyrene, as opposed to naphthalene. However,
differences in the rate of apoptosis were not as noticeable at this concentration.
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Figure 5.35. Pre-treatment of TNBC cells compared to the Non-treated cells. These results are
them compared to solvent and analyte introduction at 2.5×10-05 M concentration.
Figure 5.2 shows cellular activity after exposure to slightly higher concentration of PAHs
than those in Figure 5.1. The solvent had a slight toxic effect on the cells. Apoptosis is more
prevalent in naphthalene. Congregation and cell structural changes are noted in anthracene
exposure. The cells were aggregating more with pyrene. These structural changes are suggested to
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be the beginning of apoptosis according to the observances in Figure 5.3. Differences in the rate
of apoptosis was observed and further assessed by a cell viability assay (not shown).
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Figure 5.36. Pre-treatment of TNBC cells compared to the Non-treated cells. These results are
them compared to solvent and analyte introduction at 3.6×10-05 M concentration.
Figure 5.3 shows that pyrene has the strongest toxic affect to the cells. Pyrenes increased
conjugation by the addition and stacking of aromatic benzene rings could be a result of the
apoptotic cells.
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CHAPTER 6
6

Conclusion and Moving Forward

6.1 Conclusion and Limitations
All of the results and discussion of this thesis suggest that the activity of the analytes with
BSA and HSA are dependent on concentration and temperature. Since one of the main
characteristics of the analytes are high-hyrdrophobicity, the major contributors of PAH-BSA/HSA
interactions is by the hydrophobic pockets found in the major binding sites of both proteins. The
experimental studies evaluated throughout the duration of this thesis is vital not only for the
scientific community, but the world as a whole. Cell studies, though in the beginning stages are
showing promising results that will be studied further. It seems that the analytes are having
apoptotic effect on the triple negative breast cancer cells. One of the major limitations were time
and detachment of cells. When trying to perform cell viability, some difficulty and challenges in
detaching the cells from the cell plate were encountered. Cell viability testing was done but is not
reported because of this. There is an ongoing effort toward the development of alternative methods
of cell exposure and cleavage.
6.2 Moving Forward
Although a lot of analytical and spectroscopic were done on these particular compounds
there are still more aspects to be investigated. Next, anisotropic studies will be conducted in order
to understand more the molecular structure and the influence of PAHs on the mobility of BSA and
HSA in solution. Normalized fluorescent studies will be conducted to confirm and suggest more
definitive motion and mode of action. Studies of the interaction of more conjugated PAHs on BSA
and HSA to evaluate the role that they play in binding will be conducted. In everyday living, we
are exposed to a mixture of analytes, so in hopes understand the binding, consequently, further
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studies involving how a mixture of PAHs would bind to the proteins will be conducted. Hopefully
this will bring clarity to the competition of binding.
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